Published • loading... • Updated
Genmab Shares Jump 16% as Rally Builds on Cancer Drug Wins, JPMorgan Upgrade and Head and Neck Trial Hopes
Summary by IBTimes Australia
5 Articles
5 Articles
New trial results with a drug for head and neck cancer send Genmab's share price up.
·Aarhus, Denmark
Read Full Article
berlingske.dk+2 Reposted by 2 other sources
New trial results with a drug for head and neck cancer send Genmab's share price up.
·Copenhagen, Denmark
Read Full Article
Genmab Shares Jump 16% as Rally Builds on Cancer Drug Wins, JPMorgan Upgrade and Head and Neck Trial Hopes
Genmab shares rose 16% after encouraging ovarian and colorectal cancer trial results, a JPMorgan upgrade and stronger expectations for its experimental drug pipeline.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources5
Leaning Left0Leaning Right3Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
